Inventor · disambiguated record
Michael Campbell
Also filed as: CAMPBELL MICHAEL · CAMPBELL MICHAEL G · CAMPBELL MICHAEL GORDON · CAMPBELL MICHAEL J
17 granted patents·3 pending applications·298 citations·filing 1999–2011
94Inventor score
Top patents by PatentIndex Score
20 records- 0196US6548548B2ABCA-1 elevating compoundsCV THERAPEUTICS INC·Filed 2001·Granted Apr 15, 2003·61 cites·39 claims
- 0293US6919366B2Benzimidazole derivatives as modulators of IgEAVANIR PHARMACEUTICALS·Filed 2001·Granted Jul 19, 2005·43 cites·16 claims
- 0386US7501446B2Prenylation inhibitors and methods of their synthesis and usePPD DISCOVERY INC·Filed 2007·Granted Mar 10, 2009·7 cites·2 claims
- 0485US6919339B2ABCA-1 elevating compoundsCV THEAPEUTICS INC·Filed 2001·Granted Jul 19, 2005·17 cites·20 claims
- 0584US6911462B2Benzimidazole compounds for regulating IgEAVANIR PHARMACEUTICALS·Filed 2002·Granted Jun 28, 2005·13 cites·18 claims
- 0683US7981896B2Pyrazoles for the treatment of obesity and other CNS disordersATHERSYS INC·Filed 2011·Granted Jul 19, 2011·10 cites·4 claims
- 0783US6900219B2ABCA-1 elevating compoundsCV THERAPEUTICS INC·Filed 2003·Granted May 31, 2005·23 cites·48 claims
- 0882US6451829B2Coumarinic compounds having IgE affecting propertiesFiled 2001·Granted Sep 17, 2002·15 cites·10 claims
- 0978US7166619B2Prenylation inhibitors and methods of their synthesis and usePPD DISCOVERY INC·Filed 2003·Granted Jan 23, 2007·14 cites·103 claims
- 1078US6369091B1Benzimidazole analogs as down-regulators of IgEAVANIR PHARMACEUTICALS·Filed 1999·Granted Apr 9, 2002·51 cites·18 claims
- 1168US6271390B1Suppression of the IgE-dependent allergic response by benzimidazole analogsAVANIR PHARMACEUTICALS·Filed 1999·Granted Aug 7, 2001·22 cites·15 claims
- 1265US8129424B2Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disordersBENNANI YOUSSEF L·Filed 2010·Granted Mar 6, 2012·1 cites·3 claims
- 1365US2005246106A1Methods and systems for identifying genes, splice variants, and transcripts using an evidence mapping approachAPPLERA CORP·Filed 2004·Application pending·0 cites
- 1462US2005075343A1Benzimidazole derivatives as modulators of IgEFiled 2004·Application pending·0 cites
- 1560US6303645B1Benzimidazole derivatives as modulators of IgEAVANIR PHARMACEUTICALS·Filed 1999·Granted Oct 16, 2001·21 cites·11 claims
- 1659US7855224B2Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disordersATHERSYS INC·Filed 2008·Granted Dec 21, 2010·0 cites·1 claims
- 1759US2005277686A1Benzimidazole compounds for regulating IgESIRCAR JAGADISH C·Filed 2005·Application pending·0 cites
- 1856US7528262B2Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disordersATHERSYS INC·Filed 2006·Granted May 5, 2009·0 cites·4 claims
- 1949US7897634B2Pyrazoles for the treatment of obesity and other CNS disordersATHERSYS INC·Filed 2007·Granted Mar 1, 2011·0 cites·8 claims
- 2043US7319103B2Non-imidazole tertiary amines as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disordersATHERSYS INC·Filed 2005·Granted Jan 15, 2008·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Michael Campbell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →